Detalhe da pesquisa
1.
Proteomic patterns associated with response to breast cancer neoadjuvant treatment.
Mol Syst Biol
; 16(9): e9443, 2020 09.
Artigo
em Inglês
| MEDLINE | ID: mdl-32960509
2.
AXL and Error-Prone DNA Replication Confer Drug Resistance and Offer Strategies to Treat EGFR-Mutant Lung Cancer.
Cancer Discov
; 12(11): 2666-2683, 2022 11 02.
Artigo
em Inglês
| MEDLINE | ID: mdl-35895872
3.
Upfront admixing antibodies and EGFR inhibitors preempts sequential treatments in lung cancer models.
EMBO Mol Med
; 13(4): e13144, 2021 04 09.
Artigo
em Inglês
| MEDLINE | ID: mdl-33660397
4.
Targeting HER3, a Catalytically Defective Receptor Tyrosine Kinase, Prevents Resistance of Lung Cancer to a Third-Generation EGFR Kinase Inhibitor.
Cancers (Basel)
; 12(9)2020 Aug 24.
Artigo
em Inglês
| MEDLINE | ID: mdl-32847130
5.
Crosstalk between VEGF and novel angiogenic protein regulates tumor angiogenesis and contributes to aggressiveness of breast carcinoma.
Cell Signal
; 25(1): 277-94, 2013 Jan.
Artigo
em Inglês
| MEDLINE | ID: mdl-23000338